Michael W Rogers is of Akebia Therapeutics, Inc.. Currently has a direct ownership of 161,729 shares of AKBA, which is worth approximately $622,656. The most recent transaction as insider was on Jun 10, 2025, when has been sold 35,700 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 162K
28.33% 3M change
28.33% 12M change
Total Value Held $622,656

MICHAEL W ROGERS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2025
BUY
Grant, award, or other acquisition
-
35,700 Added 18.08%
161,729 Common Stock
Jun 06 2024
BUY
Grant, award, or other acquisition
-
30,000 Added 19.23%
126,029 Common Stock
Jun 06 2023
BUY
Grant, award, or other acquisition
-
30,000 Added 23.8%
96,029 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
13,700 Added 17.18%
66,029 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
13,700 Added 20.75%
52,329 Common Stock

Also insider at

ARAV
Aravive, Inc. Healthcare
MWR

Michael W Rogers

Houston, TX

Track Institutional and Insider Activities on AKBA

Follow Akebia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKBA shares.

Notify only if

Insider Trading

Get notified when an Akebia Therapeutics, Inc. insider buys or sells AKBA shares.

Notify only if

News

Receive news related to Akebia Therapeutics, Inc.

Track Activities on AKBA